Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Electromed, Inc.

Get SEC filing alerts via email and in your feed for Electromed, Inc.

ELMD

Electromed, Inc.

About Electromed, Inc.

Electromed, Inc. develops, manufactures, and markets the SmartVest airway clearance system, primarily serving patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions. Its products use high-frequency chest wall oscillation (HFCWO) to improve respiratory function, reduce infections, and lower healthcare costs. The company employs a direct-to-patient and provider sales model, focusing on clinical evidence, reimbursement support, and product innovation in the U.S. and select international markets.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Electromed, Inc.

1
1
Electromed, Inc. Electromed, Inc. Reports 18.4% Revenue Growth to $18.575 Million in Latest Quarter

Via official filing (AI summary) | 23 days ago | 0 comments

2
1
Electromed, Inc. Electromed Reports 16.3% Revenue Growth to $18.9 Million in Latest Quarter

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
Electromed, Inc. Electromed Reports 15.1% Revenue Growth to $16.9 Million for Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Electromed, Inc. Electromed Reports 17% Revenue Growth to $64 Million for Fiscal Year Ending June 30, 2025

Via official filing (AI summary) | 9 months ago | 0 comments

5
1
Electromed, Inc. Electromed Reports 13.1% Revenue Growth to $15.7 Million in Q3 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Electromed, Inc. Electromed Reports 18.7% Revenue Growth to $16.3 Million in Q2 Fiscal 2025

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
Electromed, Inc. Electromed, Inc. Reports 19% Revenue Growth and Improved Profitability in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments